BUZZ-Nicox: Plunges after FDA set to inspect partner's production facility
** Shares of French biotech co fall >7 pct after FDA set to inspect latanoprostene bunod production facility
** FDA has raised concerns which pertain to an inspection of the manufacturing facility of Bausch + Lomb, a Nicox partner, and a unit of Valeant
** Valeant says some deficiencies were identified by the FDA at Bausch + Lomb's production facility in Tampa, FL
** Shares were down as much as 16.6 pct minutes after open before trading was halted
** Stock top faller on French health care index
© Thomson Reuters 2017 All rights reserved.